MEAG MUNICH ERGO, KAPITALANLAGEGESELLSCHAFT MBH – Vertex Pharmaceuticals Incorporated Transaction History
MEAG MUNICH ERGO, KAPITALANLAGEGESELLSCHAFT MBH portfolio value:
$3.14M
portfolio value
MEAG MUNICH ERGO, KAPITALANLAGEGESELLSCHAFT MBH quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +414.18% | 8.76K shares | 2.55M | $289.54 | 10.87K |
Q2 2022 | share | Increase | +27.41% | 455 shares | 157K | $281.79 | 2.11K |
Q1 2022 | share | Increase | 0.00% | 1.66K shares | 439K | $260.97 | 1.66K |
Q4 2021 | share | Decrease | -100.00% | -7.17K shares | -1.30M | $222.45 | 0 |
Q3 2021 | share | 0.00% | 0 shares | -145K | $181.39 | 7.17K | |
Q2 2021 | share | Decrease | -3.96% | -296 shares | -159K | $201.63 | 7.17K |
Q1 2021 | share | Increase | +55.20% | 2.65K shares | 486K | $214.89 | 7.47K |
Q4 2020 | share | Increase | 0.00% | 4.81K shares | 1.12M | $236.34 | 4.81K |
Q3 2020 | share | Decrease | -100.00% | -5.76K shares | -1.67M | $272.12 | 0 |
Q2 2020 | share | Increase | 0.00% | 5.76K shares | 1.67M | $290.31 | 5.76K |
Q1 2020 | share | Decrease | -100.00% | -3.96K shares | -867K | $237.95 | 0 |
Q4 2019 | share | Decrease | -76.51% | -12.89K shares | -1.93M | $218.95 | 3.96K |
Q3 2019 | share | Increase | +47.17% | 5.40K shares | 750K | $169.42 | 16.85K |
Q2 2019 | share | Decrease | -8.16% | -1.01K shares | -225K | $183.38 | 11.45K |
Q1 2019 | share | Increase | +330.03% | 9.57K shares | 1.80M | $183.95 | 12.47K |
Q4 2018 | share | 0.00% | 0 shares | -75K | $165.71 | 2.9K | |
Q3 2018 | share | 0.00% | 0 shares | 115K | $192.74 | 2.9K | |
Q2 2018 | share | 0.00% | 0 shares | -29K | $169.96 | 2.9K | |
Q1 2018 | share | Decrease | -89.84% | -25.64K shares | -3.88M | $162.98 | 2.9K |
Q4 2017 | share | Increase | 0.00% | 28.54K shares | 4.34M | $149.86 | 28.54K |